Lipid Lowering for Secondary Prevention of Cardiovascular Disease in Older Adults

ISSN： 1170-229X

Source： Drugs & Aging, Vol.27, Iss.12, 2010-12, pp. : 959-972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges

By Robinson Jennifer G.

Drugs & Aging, Vol. 26, Iss. 11, 2009-11 ,pp. : 917-931

Adis International

Access to resources Recommend Favorite

Homocysteine Lowering with Folic Acid and Vitamin B Supplements: Effects on Cardiovascular Disease in Older Adults

By Carlsson Cynthia M.

Drugs & Aging, Vol. 23, Iss. 6, 2006-01 ,pp. : 491-502

Adis International

Access to resources Recommend Favorite

Lipid Management for the Prevention of Cardiovascular Disease

Current Pharmaceutical Design, Vol. 17, Iss. 9, 2011-03 ,pp. : 852-860

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial:primary Prevention of Coronary Heart Disease with Lipid Lowering Therapy

By Bernini F. Paoletti R.

Pharmacological Research, Vol. 35, Iss. 3, 1997-03 ,pp. : 167-167

Academic Press

Access to resources Recommend Favorite

Cardiovascular Implications of Chronic Kidney Disease in Older Adults

By Dukkipati Ramnath Adler Sharon Mehrotra Rajnish

Drugs & Aging, Vol. 25, Iss. 3, 2008-01 ,pp. : 241-253

Adis International

Access to resources Recommend Favorite